Author pages are created from data sourced from our academic publisher partnerships and public sources.
The role of endoscopic retrograde pancreatography in the treatment of traumatic pancreatic duct injury.
BACKGROUND The status of the main pancreatic duct (MPD) is the most important determinant of the morbidity and mortality associated with pancreatic trauma. Early diagnosis and optimal treatment are… Expand
Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
BACKGROUND & AIMS Further histological subclassification of cirrhosis may be useful because of heterogeneity of severity within cirrhosis. We aimed to determine the relationship between histological… Expand
Revision and update on clinical practice guideline for liver cirrhosis
Liver cirrhosis (LC) is a disease with a high rate of prevalence and one of the most common causes of mortality in the Republic of Korea (hereafter "Korea"). In Korea, the main etiologies of LC have… Expand
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations
- S. Sarin, A. Kumar, +32 authors Asian Pacific Association for the Study of the Liver Wor Hypertension
- Hepatology international
- 19 February 2011
BackgroundAcute variceal bleeding (AVB) is a medical emergency and associated with a mortality of 20% at 6 weeks. Significant advances have occurred in the recent past and hence there is a need to… Expand
Hepatogenous Diabetes in Cirrhosis Is Related to Portal Pressure and Variceal Hemorrhage
Background and AimThe clinical impact and complications of hepatogenous diabetes (HD) on cirrhosis have not been elucidated. This study aimed to evaluate the relationship of HD with portal… Expand
Hepatic vein arrival time as assessed by contrast‐enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis
The measurement of the hepatic venous pressure gradient (HVPG) for the estimation of portal hypertension (PH) in cirrhosis has some limitations, including its invasiveness. Hepatic vein arrival time… Expand
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.
With advances in the management and treatment of advanced liver disease, including the use of antiviral therapy, a simple, one stage description for advanced fibrotic liver disease has become… Expand
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage
Vasoactive drugs are recommended to be started as soon as possible in suspected variceal bleeding, even before diagnostic endoscopy. However, it is still unclear whether the therapeutic efficacies of… Expand
Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial
Bone marrow‐derived mesenchymal stem cell (BM‐MSC) transplantation has been suggested as an effective therapy for liver cirrhosis. The efficacy and safety of autologous BM‐MSC transplantation in the… Expand
Mesenchymal stem cell therapy for liver fibrosis
Currently, the most effective treatment for end-stage liver fibrosis is liver transplantation; however, transplantation is limited by a shortage of donor organs, surgical complications, immunological… Expand